Actinogen Medical Limited (AU:ACW) has released an update.
Actinogen Medical Limited has announced the cancellation of over 5.4 million ordinary shares as a result of an employee share scheme buy-back. The cessation of these securities took effect on April 15, 2024. This move could signal strategic financial changes within the company that may interest investors.
For further insights into AU:ACW stock, check out TipRanks’ Stock Analysis page.
